Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Amylyx Pharmaceuticals, Inc.
13G/A
Amendment 1
AMLX · 03237H101
|
1.2% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 1.2% | ||||
| Point72 Capital Advisors, Inc. | 1.2% | ||||
| Steven A. Cohen | 1.2% | ||||
|
Olema Pharmaceuticals, Inc.
13G/A
Amendment 1
OLMA · 68062P106
|
2.3% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 2.3% | ||||
| Point72 Capital Advisors, Inc. | 2.3% | ||||
| Steven A. Cohen | 2.3% | ||||
|
Annexon, Inc.
13G/A
Amendment 1
ANNX · 03589W102
|
0.1% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 0.1% | ||||
| Point72 Capital Advisors, Inc. | 0.1% | ||||
| Steven A. Cohen | 0.1% | ||||
|
JOYY Inc.
13G/A
Amendment 2
JOYY · 46591M109
|
0% |
5/15/2025
Event 3/31/2025
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
CytomX Therapeutics, Inc.
13G
CTMX · 23284F105
|
8.3% |
5/14/2025
Event 5/12/2025
|
|||
| Point72 Asset Management, L.P. | 8.3% | ||||
| Point72 Capital Advisors, Inc. | 8.3% | ||||
| Steven A. Cohen | 8.3% | ||||
|
Arcus Biosciences, Inc.
13G
RCUS · 03969F109
|
5.5% |
5/13/2025
Event 5/12/2025
|
|||
| Point72 Asset Management, L.P. | 5.5% | ||||
| Point72 Capital Advisors, Inc. | 5.5% | ||||
| Steven A. Cohen | 5.5% | ||||
|
Dianthus Therapeutics, Inc. /DE/
13G
DNTH · 252828108
|
5.9% |
4/17/2025
Event 4/10/2025
|
|||
| Point72 Asset Management, L.P. | 5.9% | ||||
| Point72 Capital Advisors, Inc. | 5.9% | ||||
| Steven A. Cohen | 5.9% | ||||
|
Cidara Therapeutics, Inc.
13G
CDTX · 171757206
|
9.1% |
4/16/2025
Event 4/9/2025
|
|||
| Point72 Asset Management, L.P. | 9.1% | ||||
| Point72 Capital Advisors, Inc. | 9.1% | ||||
| Steven A. Cohen | 9.1% | ||||
|
Regulus Therapeutics Inc.
13G
RGLS · 75915K309
|
5.9% |
4/8/2025
Event 4/1/2025
|
|||
| Point72 Asset Management, L.P. | 5.9% | ||||
| Point72 Capital Advisors, Inc. | 5.9% | ||||
| Steven A. Cohen | 5.9% | ||||
|
Shoals Technologies Group, Inc.
13G
SHLS · 82489W107
|
5.4% |
4/2/2025
Event 4/1/2025
|
|||
| Point72 Asset Management, L.P. | 5.4% | ||||
| Point72 Capital Advisors, Inc. | 5.4% | ||||
| Steven A. Cohen | 5.4% | ||||
|
Relay Therapeutics, Inc.
13G
RLAY · 75943R102
|
5.7% |
3/20/2025
Event 3/14/2025
|
|||
| Point72 Asset Management, L.P. | 5.7% | ||||
| Point72 Capital Advisors, Inc. | 5.7% | ||||
| Steven A. Cohen | 5.7% | ||||
|
VNET Group, Inc.
13G
VNET · 90138A103
|
5.0% |
3/14/2025
Event 3/14/2025
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
Mobileye Global Inc.
13G
MBLY · 60741F104
|
5.0% |
3/6/2025
Event 3/5/2025
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
PepGen Inc.
13G
PEPG · 713317105
|
5.7% |
2/28/2025
Event 2/27/2025
|
|||
| Point72 Asset Management, L.P. | 5.7% | ||||
| Point72 Capital Advisors, Inc. | 5.7% | ||||
| Steven A. Cohen | 5.7% | ||||
|
Anaptysbio, Inc
13G
ANAB · 032724106
|
5.6% |
2/18/2025
Event 2/14/2025
|
|||
| Point72 Asset Management, L.P. | 5.6% | ||||
| Point72 Capital Advisors, Inc. | 5.6% | ||||
| Steven A. Cohen | 5.6% | ||||
|
Lumentum Holdings Inc.
13G/A
Amendment 2
LITE · 55024U109
|
6.1% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 6.0% | ||||
| Point72 Capital Advisors, Inc. | 6.0% | ||||
| Point72 Italy S.R.L. | 0% | ||||
| Steven A. Cohen | 6.1% | ||||
|
Madison Square Garden Entertainment Corp.
13G/A
Amendment 2
MSGE · 558256103
|
5.5% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 5.5% | ||||
| Point72 Capital Advisors, Inc. | 5.5% | ||||
| Steven A. Cohen | 5.5% | ||||
|
PagSeguro Digital Ltd.
13G/A
Amendment 3
PAGS · G68707101
|
9.5% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 9.5% | ||||
| Point72 Capital Advisors, Inc. | 9.5% | ||||
| Steven A. Cohen | 9.5% | ||||
|
Cogent Biosciences, Inc.
13G/A
Amendment 3
COGT · 19240Q201
|
8.7% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 8.7% | ||||
| Point72 Capital Advisors, Inc. | 8.7% | ||||
| Steven A. Cohen | 8.7% | ||||
|
Praxis Precision Medicines, Inc.
13G/A
Amendment 3
PRAX · 74006W207
|
6.3% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 5.9% | ||||
| Point72 Capital Advisors, Inc. | 5.9% | ||||
| Point72 Biotech Private Investments, LLC | 0.3% | ||||
| Differentiated Ventures Investments, LLC | 0.3% | ||||
| 72 Investment Holdings, LLC | 0.3% | ||||
| Steven A. Cohen | 6.3% | ||||
|
Liberty Media Corp
13G/A
Amendment 2
LLYVA · 531229748
|
4.6% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 4.6% | ||||
| Point72 Capital Advisors, Inc. | 4.6% | ||||
| Steven A. Cohen | 4.6% | ||||
|
Syros Pharmaceuticals, Inc.
13G/A
Amendment 1
SYRS · 87184Q206
|
0% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Inhibikase Therapeutics, Inc.
13G/A
Amendment 1
IKT · 45719W205
|
0% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Avid Bioservices, Inc.
13G/A
Amendment 2
CDMO · 05368M106
|
0% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 0% | ||||
| Point72 Capital Advisors, Inc. | 0% | ||||
| Steven A. Cohen | 0% | ||||
|
Rapid7, Inc.
13G/A
Amendment 1
RPD · 753422104
|
2.4% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 2.4% | ||||
| Point72 Capital Advisors, Inc. | 2.4% | ||||
| Steven A. Cohen | 2.4% | ||||
|
Teladoc Health, Inc.
13G/A
Amendment 1
TDOC · 87918A105
|
7.2% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 7.2% | ||||
| Point72 Capital Advisors, Inc. | 7.2% | ||||
| Steven A. Cohen | 7.2% | ||||
|
Sphere Entertainment Co.
13G/A
Amendment 2
SPHR · 55826T102
|
7.3% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 7.3% | ||||
| Point72 Capital Advisors, Inc. | 7.3% | ||||
| Steven A. Cohen | 7.3% | ||||
|
Bright Minds Biosciences Inc.
13G/A
Amendment 1
DRUG · 10919W405
|
3.0% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 3.0% | ||||
| Point72 Capital Advisors, Inc. | 3.0% | ||||
| Steven A. Cohen | 3.0% | ||||
|
Shoals Technologies Group, Inc.
13G/A
Amendment 1
SHLS · 82489W107
|
3.3% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 3.3% | ||||
| Point72 Capital Advisors, Inc. | 3.3% | ||||
| Point72 Europe (London) LLP | 0% | ||||
| Steven A. Cohen | 3.3% | ||||
|
Alto Neuroscience, Inc.
13G/A
Amendment 1
ANRO · 02157Q109
|
8.8% |
2/14/2025
Event 12/31/2024
|
|||
| Point72 Asset Management, L.P. | 6.3% | ||||
| Point72 Capital Advisors, Inc. | 6.3% | ||||
| Point72 Biotech Private Investments, LLC | 2.5% | ||||
| Differentiated Ventures Investments, LLC | 2.5% | ||||
| 72 Investment Holdings, LLC | 2.5% | ||||
| Steven A. Cohen | 8.8% | ||||
|
Tower Semiconductor Ltd
13G
TSEM · M87915274
|
5.1% |
2/13/2025
Event 2/12/2025
|
|||
| Point72 Asset Management, L.P. | 5.1% | ||||
| Point72 Capital Advisors, Inc. | 5.1% | ||||
| Steven A. Cohen | 5.1% | ||||
|
Immunome Inc.
13G
IMNM · 45257U108
|
5.9% |
2/3/2025
Event 1/31/2025
|
|||
| Point72 Asset Management, L.P. | 5.9% | ||||
| Point72 Capital Advisors, Inc. | 5.9% | ||||
| Steven A. Cohen | 5.9% | ||||
|
Dyne Therapeutics, Inc.
13G
DYN · 26818M108
|
5.1% |
2/3/2025
Event 1/31/2025
|
|||
| Point72 Asset Management, L.P. | 5.1% | ||||
| Point72 Capital Advisors, Inc. | 5.1% | ||||
| Steven A. Cohen | 5.1% | ||||
|
Aadi Bioscience, Inc.
13G
WHWK · 00032Q104
|
6.0% |
1/29/2025
Event 1/22/2025
|
|||
| Point72 Asset Management, L.P. | 6.0% | ||||
| Point72 Capital Advisors, Inc. | 6.0% | ||||
| Steven A. Cohen | 6.0% | ||||
|
Ventyx Biosciences, Inc.
13G
VTYX · 92332V107
|
6.2% |
1/29/2025
Event 1/22/2025
|
|||
| Point72 Asset Management, L.P. | 6.2% | ||||
| Point72 Capital Advisors, Inc. | 6.2% | ||||
| Steven A. Cohen | 6.2% | ||||
|
Syndax Pharmaceuticals Inc
13G
SNDX · 87164F105
|
5.0% |
1/22/2025
Event 1/21/2025
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
Amylyx Pharmaceuticals, Inc.
13G
AMLX · 03237H101
|
5.6% |
1/14/2025
Event 1/13/2025
|
|||
| Point72 Asset Management, L.P. | 5.6% | ||||
| Point72 Capital Advisors, Inc. | 5.6% | ||||
| Steven A. Cohen | 5.6% | ||||
|
Array Technologies, Inc.
13G
ARRY · 04271T100
|
5.0% |
1/13/2025
Event 1/10/2025
|
|||
| Point72 Asset Management, L.P. | 5.0% | ||||
| Point72 Capital Advisors, Inc. | 5.0% | ||||
| Steven A. Cohen | 5.0% | ||||
|
Entera Bio Ltd.
13G
ENTX · M40527109
|
6.8% |
1/6/2025
Event 1/3/2025
|
|||
| Point72 Asset Management, L.P. | 6.8% | ||||
| Point72 Capital Advisors, Inc. | 6.8% | ||||
| Steven A. Cohen | 6.8% | ||||
|
StoneCo Ltd.
13G
STNE · G85158106
|
5.1% |
12/30/2024
Event 12/27/2024
|
|||
| Point72 Asset Management, L.P. | 5.1% | ||||
| Point72 Capital Advisors, Inc. | 5.1% | ||||
| Steven A. Cohen | 5.1% | ||||
|
Bicycle Therapeutics PLC
13G
BCYC · 088786108
|
8.9% |
12/20/2024
Event 12/13/2024
|
|||
| Point72 Asset Management, L.P. | 8.9% | ||||
| Point72 Capital Advisors, Inc. | 8.9% | ||||
| Steven A. Cohen | 8.9% | ||||